CONCENTRATION OF RISK	6 Months Ended
CONCENTRATION OF RISK	Jun. 30, 2014
Risks and Uncertainties [Abstract]
Concentration of Risk	CONCENTRATION OF RISK Customer and Credit Risk The Company provides trade credit to its customers in the normal course of business. One payor, UnitedHealthcare, accounted for approximately 22% and 23% of revenue during the three months ended June 30, 2014 and 2013, respectively, and 22% and 23% for the six months ended June 30, 2014 and 2013, respectively. The revenue is related to the Infusion Services segment. Therapy Revenue Risk The Company sells products related to the Immune Globulin therapy, which represented 17% and 20% of revenue during the three months ended June 30, 2014 and 2013, respectively, and 18% and 19% for the six months ended June 30, 2014 and 2013, respectively. The revenue is related to the Infusion Services segment.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References+ Details